MedApp S.A. (WSE:MDA)
Poland flag Poland · Delayed Price · Currency is PLN
0.1710
-0.0015 (-0.87%)
At close: Mar 28, 2025

MedApp Statistics

Total Valuation

MedApp has a market cap or net worth of PLN 39.02 million. The enterprise value is 44.96 million.

Market Cap 39.02M
Enterprise Value 44.96M

Important Dates

The last earnings date was Monday, March 17, 2025.

Earnings Date Mar 17, 2025
Ex-Dividend Date n/a

Share Statistics

MedApp has 250.13 million shares outstanding.

Current Share Class n/a
Shares Outstanding 250.13M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 120.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.26
PB Ratio 1.64
P/TBV Ratio 3.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.45, with an EV/FCF ratio of -54.16.

EV / Earnings -232.94
EV / Sales 6.06
EV / EBITDA 9.45
EV / EBIT n/a
EV / FCF -54.16

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.12.

Current Ratio 2.67
Quick Ratio 1.94
Debt / Equity 0.12
Debt / EBITDA 0.69
Debt / FCF -3.97
Interest Coverage 0.30

Financial Efficiency

Return on equity (ROE) is -0.46% and return on invested capital (ROIC) is 0.09%.

Return on Equity (ROE) -0.46%
Return on Assets (ROA) 0.08%
Return on Invested Capital (ROIC) 0.09%
Return on Capital Employed (ROCE) 0.16%
Revenue Per Employee 463,813
Profits Per Employee -12,063
Employee Count 16
Asset Turnover 0.20
Inventory Turnover 0.80

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -52.50% in the last 52 weeks. The beta is 0.95, so MedApp's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change -52.50%
50-Day Moving Average 0.18
200-Day Moving Average 0.21
Relative Strength Index (RSI) 34.22
Average Volume (20 Days) 33,624

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MedApp had revenue of PLN 7.42 million and -193,000 in losses. Loss per share was -0.00.

Revenue 7.42M
Gross Profit 2.59M
Operating Income 44,000
Pretax Income -98,000
Net Income -193,000
EBITDA 4.76M
EBIT 44,000
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 123,000 in cash and 3.30 million in debt, giving a net cash position of -3.17 million or -0.01 per share.

Cash & Cash Equivalents 123,000
Total Debt 3.30M
Net Cash -3.17M
Net Cash Per Share -0.01
Equity (Book Value) 26.61M
Book Value Per Share 0.10
Working Capital 16.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -789,000 and capital expenditures -41,000, giving a free cash flow of -830,000.

Operating Cash Flow -789,000
Capital Expenditures -41,000
Free Cash Flow -830,000
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross margin is 34.83%, with operating and profit margins of 0.59% and -2.60%.

Gross Margin 34.83%
Operating Margin 0.59%
Pretax Margin -1.32%
Profit Margin -2.60%
EBITDA Margin 64.10%
EBIT Margin 0.59%
FCF Margin n/a

Dividends & Yields

MedApp does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -0.49%
FCF Yield -2.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MedApp has an Altman Z-Score of 4.37.

Altman Z-Score 4.37
Piotroski F-Score n/a